Cargando…

Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes

To determine whether continuous subcutaneous insulin infusion (CSII) vs. multiple daily injections (MDI) therapy from near-diagnosis of type 1 diabetes is associated with reduced glycaemic variability (GV) and altered microRNA (miRNAs) expression. Adolescents (74% male) within 3-months of diabetes d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Emma S., Januszewski, Andrzej S., Carroll, Luke M., Fulcher, Gregory R., Joglekar, Mugdha V., Hardikar, Anandwardhan A., Jones, Timothy W., Davis, Elizabeth A., Jenkins, Alicia J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370996/ https://www.ncbi.nlm.nih.gov/pubmed/34404828 http://dx.doi.org/10.1038/s41598-021-95824-8

Ejemplares similares

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
por: Scott, Emma S, et al.
Publicado: (2019)

Directed differentiation into insulin-producing cells using microRNA manipulation
por: Williams, Michael D., et al.
Publicado: (2020)

Circulating microRNAs: Understanding the Limits for Quantitative Measurement by Real‐Time PCR
por: Hardikar, Anandwardhan A., et al.
Publicado: (2014)

Insulin micro-secretion in Type 1 diabetes and related microRNA profiles
por: Januszewski, Andrzej S., et al.
Publicado: (2021)

A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy
por: Farr, Ryan J., et al.
Publicado: (2015)

MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review
por: Barraclough, Jennifer Y., et al.
Publicado: (2019)

MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury
por: Shihana, Fathima, et al.
Publicado: (2023)

Comparative analysis of diagnostic platforms for measurement of differentially methylated insulin DNA
por: Farr, Ryan J., et al.
Publicado: (2019)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Islet-like cell clusters occur naturally in human gall bladder and are retained in diabetic conditions†
por: Sahu, Subhshri, et al.
Publicado: (2009)

Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis
por: Alvandi, Ehsan, et al.
Publicado: (2022)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Postpartum Circulating Cell-Free Insulin DNA Levels Are Higher in Women with Previous Gestational Diabetes Mellitus Who Develop Type 2 Diabetes in Later Life
por: Lappas, Martha, et al.
Publicado: (2019)

Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2019)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Urinary microRNAs as non-invasive biomarkers for toxic acute kidney injury in humans
por: Shihana, Fathima, et al.
Publicado: (2021)

Manipulating cellular microRNAs and analyzing high-dimensional gene expression data using machine learning workflows
por: Saini, Vijit, et al.
Publicado: (2021)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

An Optimised Step-by-Step Protocol for Measuring Relative Telomere Length
por: Joglekar, Mugdha V., et al.
Publicado: (2020)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
por: Hauzenberger, Jasmin R., et al.
Publicado: (2017)

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications
por: Zabeen, Bedowra, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis
por: Yang, Bei, et al.
Publicado: (2023)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar
por: Petrovski, Goran, et al.
Publicado: (2018)

The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature
por: Da’as, Sahar I., et al.
Publicado: (2023)

Phlda3 regulates beta cell survival during stress
por: Bensellam, Mohammed, et al.
Publicado: (2019)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Analysis of Half a Billion Datapoints Across Ten Machine-Learning Algorithms Identifies Key Elements Associated With Insulin Transcription in Human Pancreatic Islet Cells
por: Wong, Wilson K. M., et al.
Publicado: (2022)

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds
por: McKee, Alexis M., et al.
Publicado: (2021)

Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
por: Nakamura, Tomoaki, et al.
Publicado: (2014)

Machine learning workflows identify a microRNA signature of insulin transcription in human tissues
por: Wong, Wilson K.M., et al.
Publicado: (2021)

Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes
por: Jotic, Aleksandra, et al.
Publicado: (2020)

Evaluation of an Algorithm to Guide Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels: A randomized controlled trial
por: Jenkins, Alicia J., et al.
Publicado: (2010)

Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2j617ae7jk4evka260i56rknsf